Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Therapeutic Potential of Metformin in Neurodegenerative Diseases
Carola Rotermund, Gerrit Machetanz, Julia C. Fitzgerald
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 255

Showing 26-50 of 255 citing articles:

Excitotoxicity as a Target Against Neurodegenerative Processes
O Binvignat, Jordi Olloquequi
Current Pharmaceutical Design (2020) Vol. 26, Iss. 12, pp. 1251-1262
Closed Access | Times Cited: 82
Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system
Sarah Demaré, Asha Kothari, Nigel A. Calcutt, et al.
Expert Review of Neurotherapeutics (2020) Vol. 21, Iss. 1, pp. 45-63
Open Access | Times Cited: 80
Mitochondrial complex I as a therapeutic target for Alzheimer's disease
Eugenia Trushina, Sergey Trushin, Md Fayad Hasan
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 483-495
Open Access | Times Cited: 76
Metformin: An old drug against old age and associated morbidities
Teresa Salvatore, Pia Clara Pafundi, Floriana Morgillo, et al.
Diabetes Research and Clinical Practice (2020) Vol. 160, pp. 108025-108025
Closed Access | Times Cited: 74
Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis
Fan Ping, Ning Jiang, Yuxiu Li
BMJ Open Diabetes Research & Care (2020) Vol. 8, Iss. 1, pp. e001370-e001370
Open Access | Times Cited: 73
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease
Steven N. Austad, Scott W. Ballinger, Thomas W. Buford, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 511-531
Open Access | Times Cited: 58
Exploring the Pharmacological Potential of Metformin for Neurodegenerative Diseases
Ming‐Rui Du, Quan-You Gao, Chenlin Liu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 48
High and stable ATP levels prevent aberrant intracellular protein aggregation in yeast
Masak Takaine, Hiromi Imamura, Satoshi Yoshida
eLife (2022) Vol. 11
Open Access | Times Cited: 43
Metformin in therapeutic applications in human diseases: its mechanism of action and clinical study
Yang Du, Yajuan Zhu, Yixin Zhou, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 42
Type 2 Diabetes (T2DM) and Parkinson’s Disease (PD): a Mechanistic Approach
S. Sri Sabari, Kiruthika Balasubramani, Mahalaxmi Iyer, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 8, pp. 4547-4573
Open Access | Times Cited: 35
Permeability of Metformin across an In Vitro Blood–Brain Barrier Model during Normoxia and Oxygen-Glucose Deprivation Conditions: Role of Organic Cation Transporters (Octs)
Sejal Sharma, Yong Zhang, Khondker Ayesha Akter, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1357-1357
Open Access | Times Cited: 31
Mode of action of Akkermansia muciniphila in the intestinal dialogue: role of extracellular proteins, metabolites and cell envelope components
Anneleen Segers, Willem M. de Vos
Microbiome Research Reports (2023) Vol. 2, Iss. 2, pp. 6-6
Open Access | Times Cited: 30
Metformin in elderly type 2 diabetes mellitus: dose-dependent dementia risk reduction
Mingyang Sun, Wan‐Ming Chen, Szu‐Yuan Wu, et al.
Brain (2023) Vol. 147, Iss. 4, pp. 1474-1482
Closed Access | Times Cited: 24
Neuroinflammation and Epilepsy: From Pathophysiology to Therapies Based on Repurposing Drugs
Pascual Sanz, Teresa Rubio, María Adelaida García-Gimeno
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4161-4161
Open Access | Times Cited: 16
DPP-4 inhibition by linagliptin ameliorates age-related mild cognitive impairment by regulating microglia polarization in mice
Fen Zhuge, Liujie Zheng, Yuxiang Pan, et al.
Experimental Neurology (2024) Vol. 373, pp. 114689-114689
Closed Access | Times Cited: 10
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial
Anna-Victoria De Keersmaecker, Eline Van Doninck, Veronica Popescu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Metformin as a disease-modifying therapy in osteoarthritis: bridging metabolism and joint health
Iryna Halabitska, Pavlo Petakh, Oleksandr Kamyshnyi
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
Samson Mathews Samuel, Elizabeth Varghese, Peter Kubatka, et al.
Biomolecules (2019) Vol. 9, Iss. 12, pp. 846-846
Open Access | Times Cited: 73
Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences
Domenico Sergi, Justine Renaud, Nicola Simola, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 69
The Neuroprotective Effect of Doxycycline on Neurodegenerative Diseases
Flávia V. Santa-Cecília, Caio A. Leite, Elaine Aparecida Del Bel, et al.
Neurotoxicity Research (2019) Vol. 35, Iss. 4, pp. 981-986
Closed Access | Times Cited: 65
Neuromodulatory effects of anti-diabetes medications: A mechanistic review
Habib Yaribeygi, Milad Ashrafizadeh, Neil C. Henney, et al.
Pharmacological Research (2019) Vol. 152, pp. 104611-104611
Closed Access | Times Cited: 61
Metformin Protects From Rotenone–Induced Nigrostriatal Neuronal Death in Adult Mice by Activating AMPK-FOXO3 Signaling and Mitigation of Angiogenesis
Sabah H. El-Ghaiesh, Hoda I. Bahr, Afaf T. Ibrahiem, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 58
Metformin regulates astrocyte reactivity in Parkinson's disease and normal aging
Young‐Kyoung Ryu, Jun Go, Hye‐Yeon Park, et al.
Neuropharmacology (2020) Vol. 175, pp. 108173-108173
Closed Access | Times Cited: 58
Neuroprotective potential of antihyperglycemic drug metformin in streptozocin-induced rat model of sporadic Alzheimer's disease
Vladimirs Piļipenko, Karīna Narbute, Jolanta Pupure, et al.
European Journal of Pharmacology (2020) Vol. 881, pp. 173290-173290
Closed Access | Times Cited: 53
Mechanistic insight into the role of metformin in Alzheimer's disease
Mehdi Sanati, Samaneh Aminyavari, Amir R. Afshari, et al.
Life Sciences (2022) Vol. 291, pp. 120299-120299
Closed Access | Times Cited: 36

Scroll to top